Total revenues
 |
$5.4 billion
 |
$4.8 billion
 |
13%
 |

Operating earnings**
|
$421.1 million |
$308.8 million |
36% |
|
Net income
|
$424.0 million |
$365.8 million |
16% |
|
Per share results:
|
|
|
|
|
Operating earnings**
|
$1.38 |
$0.96 |
44% |
|
Favorable development of prior-period health care cost estimates
|
(0.28) |
(0.08) |
|
|
Operating earnings, excluding development**
|
$1.10 |
$0.88 |
25% |
|
Income from continuing operations
|
$1.39 |
$1.02 |
|
|
Income from discontinued operations***
|
- - |
0.12 |
|
|
Net income |
$1.39 |
$1.14 |
22% |
|
Weighted average common shares (diluted) |
306.0 million |
320.8 million |
(4.6%) |
* Prior-period results per common share have been adjusted to reflect the March 11, 2005, two-for-one stock split.
** For a full description of operating earnings and per share operating earnings, please see footnote 1 at end of press release.
*** Income from discontinued operations of $40 million for first quarter 2004 reflects the completion of certain Internal Revenue Services audits associated with businesses previously sold.
|